Read more

October 08, 2022
1 min read
Save

Arthroscopic rotator cuff repair decreased pain, improved outcomes in patients of all ages

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ATLANTA — Arthroscopic repair of massive rotator cuff tears decreased pain, improved clinical outcomes and increased return to activity in patients of all ages, according to presented data.

“There are various definitions for [massive rotator cuff tears] (MRCTs), and increased age has been reported as a negative predictor as well as for healing and outcomes,” Matthew T. Provencher, MD, MBA, MC, USNR (ret.), said in his presentation at the American Shoulder and Elbow Surgeons Annual Meeting, here.

Shoulder pain
Source: Adobe Stock

Provencher and colleagues at the Steadman Philippon Research Institute analyzed data on 51 patients (mean age of 59.7 years; range of 39 to 74 years) who underwent 53 arthroscopic rotator cuff repairs (ARCRs) of a MRCT between February 2006 and October 2016. Outcome measures included ASES, SANE, Quick Disabilities of the Arm, Shoulder and Hand Score (QuickDASH), short form 12 physical component summary (SF-12 PCS), patient satisfaction, subsequent surgery and conversion to reverse shoulder arthroplasty.

Matthew T. Provencher
Matthew T. Provencher

At a minimum follow-up of 5 years, 46 shoulders had complete outcomes scores. Mean ASES scores improved from 58.7 to 96.9; mean SANE scores improved from 60.2 to 90.8; mean QuickDASH scores improved from 34.9 to 8.4; and mean SF-12 PCS scores improved from 40.8 to 52.6. Median patient satisfaction scores were 10 out of 10. Provencher and colleagues concluded Goutallier grade and age were not associated with any outcome measures.

“Overall, we demonstrated significantly improved clinical scores, decreased pain, increased return to activity at midterm follow-up, irrespective of patient age,” Provencher said. “We still need more time, more patients and probably multicenter data to really see how these are going to do over time,” he said.